Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300998 · ClinicalTrials.gov registry record
Study of CAR-T Therapy in Older Patients
A clinical trial of Multiple Myeloma and Lymphoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 154
- Enrollment target
- 1
- Study location
NCT04300998 is a study of Multiple Myeloma and Lymphoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 154 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04300998, a study of Multiple Myeloma and Lymphoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of life study and participating in the study does not involve receiving any treatment, other than the standard treatment for participants' disease.
Conditions Studied
Interventions
- BEHAVIORAL Activities of Daily Living/ADLs
- BEHAVIORAL Instrumental Activity of Daily Living
- BEHAVIORAL Timed Up and Go
- BEHAVIORAL Cognition
- BEHAVIORAL Geriatric Depression Scale
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2026-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04300998
The ClinicalTrials.gov registry entry for NCT04300998 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (72% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 5 interventions - of which Activities of Daily Living/ADLs is the first listed.
NCT04300998 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04300998 about?
NCT04300998 is a clinical study titled "Study of CAR-T Therapy in Older Patients". This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of life study and participating in the study does not involve receiving any treatment, other than the standard treatment for participants' dise...
What is the current status of trial NCT04300998?
This trial is currently recruiting. The enrollment target is 154 participants. The study started on 2020-03-04. Estimated completion is 2026-03-04.
What conditions does trial NCT04300998 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Lymphoma, B-Cell, High Grade B-Cell Lymphoma, Dlbcl NOS.
What interventions are being tested in trial NCT04300998?
The interventions under investigation include: Activities of Daily Living/ADLs (BEHAVIORAL), Instrumental Activity of Daily Living (BEHAVIORAL), Timed Up and Go (BEHAVIORAL), Cognition (BEHAVIORAL), Geriatric Depression Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT04300998?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04300998 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.